Loss of WNT5A has been associated with poor prognosis in a number of different cancer types such as breast cancer, colon cancer, neuroblastoma, and leukemia, thus suggesting a tumor-suppressive function of WNT5A in these tumor subtypes [18]. This evidence concerns the gene WNT5A and breast carcinoma.